Aimoto, Yutaro et al. published their research in Chemical Communications (Cambridge, United Kingdom) in 2018 | CAS: 2213-63-0

2,3-Dichloroquinoxaline (cas: 2213-63-0) belongs to quinoxaline derivatives. Quinoxalines have received a significant amount of attention due to their potential use in fighting various pathophysiological conditions like epilepsy, Parkinson鈥檚, and Alzheimer鈥檚 diseases. Quinoxaline-1,4-di-N-oxide derivatives have shown to improve the biological results and are endowed with anti-viral, anti-cancer, anti-bacterial, and anti-protozoal activities with application in many other therapeutic areas.Application of 2213-63-0

A family of molecular nickel hydrogen evolution catalysts providing tunable overpotentials using ligand-centered proton-coupled electron transfer paths was written by Aimoto, Yutaro;Koshiba, Keita;Yamauchi, Kosei;Sakai, Ken. And the article was included in Chemical Communications (Cambridge, United Kingdom) in 2018.Application of 2213-63-0 This article mentions the following:

Two new nickel dithiolate derivatives have been examined for their electrocatalytic activity for the hydrogen evolution reaction (HER) in attempts to clarify whether the overpotential for the HER can be tuned upon varying the ligand-centered reduction potential that triggers the HER by the catalysts. We demonstrate the validity of this approach to achieve desirable tunability in the overpotential for the HER. In the experiment, the researchers used many compounds, for example, 2,3-Dichloroquinoxaline (cas: 2213-63-0Application of 2213-63-0).

2,3-Dichloroquinoxaline (cas: 2213-63-0) belongs to quinoxaline derivatives. Quinoxalines have received a significant amount of attention due to their potential use in fighting various pathophysiological conditions like epilepsy, Parkinson鈥檚, and Alzheimer鈥檚 diseases. Quinoxaline-1,4-di-N-oxide derivatives have shown to improve the biological results and are endowed with anti-viral, anti-cancer, anti-bacterial, and anti-protozoal activities with application in many other therapeutic areas.Application of 2213-63-0

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider